2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis

Objective To develop recommendations for prevention and treatment of glucocorticoid‐induced osteoporosis (GIOP). Methods We conducted a systematic review to synthesize the evidence for the benefits and harms of GIOP prevention and treatment options. The Grading of Recommendations Assessment, Develop...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arthritis & rheumatology (Hoboken, N.J.) N.J.), 2017-08, Vol.69 (8), p.1521-1537
Hauptverfasser:	Buckley, Lenore, Guyatt, Gordon, Fink, Howard A., Cannon, Michael, Grossman, Jennifer, Hansen, Karen E., Humphrey, Mary Beth, Lane, Nancy E., Magrey, Marina, Miller, Marc, Morrison, Lake, Rao, Madhumathi, Robinson, Angela Byun, Saha, Sumona, Wolver, Susan, Bannuru, Raveendhara R., Vaysbrot, Elizaveta, Osani, Mikala, Turgunbaev, Marat, Miller, Amy S., McAlindon, Timothy
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Biocompatibility Bone Density Conservation Agents - therapeutic use Calcium Calcium, Dietary - therapeutic use Children Consensus Decision making Denosumab - therapeutic use Diphosphonates - therapeutic use Drugs Estrogen receptors Evaluation Glucocorticoids Glucocorticoids - adverse effects Humans Monoclonal antibodies Osteoporosis Osteoporosis - chemically induced Osteoporosis - drug therapy Osteoporosis - prevention & control Osteoporotic Fractures - chemically induced Osteoporotic Fractures - drug therapy Osteoporotic Fractures - prevention & control Parathyroid hormone Patients Populations Prevention Quality Raloxifene Raloxifene Hydrochloride - therapeutic use Rheumatic Diseases - drug therapy Rheumatology Societies, Medical Switching Teriparatide - therapeutic use Transplants United States Vitamin D Vitamin D - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!